« Previous
Next »
Thrombosis Research
Volume 122
, Pages S16-S19
, 2008
Phase 1 study of human plasma-derived plasmin (TAL-05-00018) in hemodialysis graft occlusion
References
- Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results. AJR Am J Roentgenol. 1989;152:1097–1100
- . Transcatheter treatment of thrombosed hemodialysis access grafts. AJR Am J Roentgenol. 1995;164:823–829
- Alteplase for hemodialysis access graft thrombolysis. J Vasc Interv Radiol. 2002;13:775–784
- . Towards safer thrombolytic therapy. Semin Hematol. 2002;39:206–216
- . The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. Ann Intern Med. 1979;90:802–808
- . Selective clot lysis with low-dose streptokinase. Radiology. 1974;111:31–37
- . Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol. 2000;11:295–298
- . The plasminogen-plasmin system. Prog Cardiovasc Dis. 1991;34:135–164
- . On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen. Biochim Biophys Acta. 1979;579:142–154
- . On the regulation and control of fibrinolysis. Thromb Haemost. 1980;43:77–89
- Thrombosed hemodialysis grafts: percutaneous mechanical balloon declotting versus thrombolysis. Radiology. 1995;196:73–77
- R.D. Shlansky-Goldberg, A.H. Matsumoto, G.A. Baumbach, et al. A first-in-human phase 1 trial of locally-delivered human plasmin for hemodialysis graft occlusion. J Thromb Haemost 2008, Apr 2 [Electronic publication ahead of print] in press.
PII: S0049-3848(08)00240-5
doi: 10.1016/j.thromres.2008.06.020
© 2008 Elsevier Ltd. All rights reserved.
« Previous
Next »
Thrombosis Research
Volume 122
, Pages S16-S19
, 2008
